Darin Talley, MD
Orthopaedic Surgery · Branson, MONPI 1548340359
Payments from drug & device makers
Across 75 payments — averaging $140.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Arthrex$3K
- Titan Surgical Group, LLC$2K
- Johnson & Johnson$2K
- Medical Device Business Services, Inc.$82
- Treace Medical Concepts, Inc.$76
- plus $163 from 5 others
What the payments were for
- Travel & lodging$5,57053%
- Food & beverage$3,77836%
- Education$1,20011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 29 | $4,253 |
| Arthrex | 19 | $2,501 |
| Titan Surgical Group, LLC | 10 | $1,873 |
| Johnson & Johnson | 8 | $1,601 |
| Medical Device Business Services, Inc. | 3 | $82 |
| Treace Medical Concepts, Inc. | 1 | $76 |
| Novastep Inc. | 1 | $54 |
| KCI USA, Inc. | 1 | $34 |
| Exactech, Inc. | 1 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Solventum Corporation | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ATTUNE$1,142
- INFINITY$1,092
- PROPHECY$840
- STAR$735
- INBONE$503
- AUGMENT INJECTABLE$145
- Velys$138
- INFINITY ADAPTIS$131
How this compares
$10,548 in reported general payments places this provider in the 65th percentile of 455 orthopaedic surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 98 | $1,357 |
| Tranexamic Acid | 41 | $624 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 85 | $577 |
| Oxycodone Hcl | 84 | $559 |
| Celecoxib | 23 | $439 |
| Cephalexin | 43 | $303 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $246 |
| Tramadol Hcl | 83 | $190 |
| Duloxetine Hcl | 25 | $169 |
| Meloxicam | 58 | $152 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $96 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Branson
- Chris ReevesBranson$49K
- Matthew SmithColumbia$4M
- Jay KeenerSaint Louis$2.2M
- John WatsonSaint Louis$1.7M
- Alexandra StrongN Kansas City$1.1M
- Thomas McCormackKansas City$852K
- Michael SnyderJefferson City$676K
- Peter ChalmersSaint Louis$674K
- Paul FrewinSullivan$630K
- Katherine BurnsBridgeton$491K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.